Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Heart Attacks without Chest Pain More Often Fatal

11.08.2004


People who have heart attacks or other heart conditions who do not experience chest pain are commonly overlooked and undertreated at the hospital, often resulting in greater fatality rates in this group of patients. A new study in the August issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians, shows that cardiac patients presenting to the hospital without chest pain have triple the death rate of other cardiac patients and are less likely to receive medications to slow the progression of a heart attack.



“While the majority of people who have acute coronary syndromes, such as heart attacks and unstable angina, feel chest pain, some do not, but, instead, may experience atypical symptoms of fainting, shortness of breath, excessive sweating, or nausea and vomiting” said the study’s lead author, David Brieger, MBBS, PhD, Concord Hospital, Sydney, Australia. “Other than excessive sweating, each of the dominant symptoms of a heart attack not accompanied by chest pain independently identifies a population that is at increased risk of dying.”

A group of international researchers analyzed data from the Global Registry of Acute Coronary Events (GRACE), a registry of 20,881 patients from 14 countries, including the United States, Canada, Australia, Great Britain, and France. These patients were hospitalized with a variety of heart conditions from July 1999 to June 2002. Of the 1,763 cardiac patients who did not experience chest pain, 13 percent died in the hospital compared to 4.3 percent of those with chest pain. In addition, 23.8 percent of patients without chest pain were initially misdiagnosed when they arrived at the hospital, compared to only 2.4 percent of heart patients who experienced typical symptoms. Patients without chest pain tended to be older women and to have a history of diabetes, heart failure, or hypertension, as opposed to patients with chest pain who were more likely to be smokers with plaque buildup in their coronary arteries. Patients with atypical symptoms were also more likely to have the unfavorable outcomes of heart failure, cardiogenic shock, arrhythmias, and renal failure.


“Often, when a patient arrives at the hospital without chest pain, it is only after blood test results come back or other diagnoses are excluded that the physician reassesses the situation and determines it is an acute cardiac event after all,” said Professor Brieger. “We hope that our findings will remind physicians that these events do occur in the absence of chest pain and will prompt them to make the diagnoses and institute the appropriate treatment more rapidly.”

Researchers also discovered that patients who did not experience chest pain were often not given proper medication or offered appropriate cardiac medical procedures. Drugs such as aspirin and beta-blockers are usually given to patients with heart problems when they arrive at the hospital because they act as blood thinners, lesson the burden on the heart, and decrease the chances of a future coronary event; yet patients who did not have chest pain were significantly less likely to receive these drugs both during their first 24 hours of hospitalization and throughout their hospital stay. These patients were also less likely to undergo procedures such as coronary angiography and percutaneous coronary intervention and were less likely to receive statins at hospital discharge.

“The current gap in treatment and hospital outcomes for patients with atypical symptoms is a problem that needs to be rectified,” said Richard S. Irwin, MD, FCCP, President of the American College of Chest Physicians. “More emphasis needs to be given to identifying and properly treating heart attacks in patients who do not exhibit typical symptoms.”

| newswise
Further information:
http://www.chestnet.org
http://www.chestjournal.org

More articles from Health and Medicine:

nachricht Improving memory with magnets
28.03.2017 | McGill University

nachricht Graphene-based neural probes probe brain activity in high resolution
28.03.2017 | Graphene Flagship

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Transport of molecular motors into cilia

28.03.2017 | Life Sciences

A novel hybrid UAV that may change the way people operate drones

28.03.2017 | Information Technology

NASA spacecraft investigate clues in radiation belts

28.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>